These two North African countries are thus in line with the WHO recommendations.
The debate about hydroxychloroquine in the fight against Covid-19, if it continues elsewhere, has been closed in Morocco. While the World Health Organization has just suspended the trials, particularly after the publication of a study in The Lancet, the prestigious British journal specialized in scientific research, because “the risk of death associated with this treatment is too high”, the Kingdom of Morocco intends to continue with the so-called Raoult protocol.
While in France, the High Council of Public Health recommends limiting the use of hydroxychloroquine, in Morocco, the health authorities have decided to continue the chloroquine treatment. Indeed, according to the Moroccan press, L’Economiste in particular, “Morocco, which has generalized treatment with Chloroquine, does not adhere to the conclusions of the study by the British journal The Lancet nor to the WHO’s decision concerning the “temporary” suspension of studies conducted with hydroxychloroquine and Chloroquine”.
According to the Moroccan government, “Opinions differ. But the main thing is that Chloroquine is involved in viral inactivation. According to Khalid Aït Taleb, Moroccan Minister of Health, “the virus infects the host by entering the cell in several stages. One of the stages is inhibited by chloroquine”. The Moroccan press recalls that the royal authorities had announced, on 8 April last, the “start of treatment with chloroquine and the control of cure in Covid-19 patients”.
The Economist recalls that “of the 7,556 cases of Covid-19 identified in Morocco on 26 May 2020, at 10 a.m., 4,841 were cured by following the Chloroquine Protocol. The others are being treated”. The newspaper, recalling the positive effects observed on patients treated according to the protocol adopted by the scientific committee, Khalid Aït Taleb had “authorized this treatment for possible cases of symptomatic Covid-19, without waiting for virology results, and while considering stopping treatment if the test proves negative”.
Anaesthetist and resuscitator in Fez, Dr. Mounir Mikou believes that “Morocco is right to maintain its treatment protocol which has proven its therapeutic effectiveness (…)”. He deplores: “Like many scientists, I want to cry out my frustration about the untruths surrounding this disease and the multitude of studies that confuse us and create a lack of confidence and credibility.
In Algeria, Dr. Mohamed Bekkat, a member of the scientific committee monitoring the evolution of the Covid-19 pandemic and president of the Algerian Medical Council, told AFP: “We have treated thousands of cases with this drug with great success to date. And we have not noted any adverse reactions”, adding that “we have not recorded any deaths linked to the use of Chloroquine”.